Decision to list medical devices supplied by Bio Serve N.Z. Limited
What we’re doing
We are pleased to announce the approval of a listing agreement with Bio Serve N.Z Limited (“Bio Serve”) for the supply of medical devices in the following categories:
In summary this will result in:
- Bio Serve’s medical devices in the above categories being listed in Part III of Section H of the Pharmaceutical Schedule from 1 August 2024 under a national agreement that all Health New Zealand | Te Whatu Ora (“Health NZ”) hospitals may purchase under; and
- Health NZ hospitals being able to purchase other suppliers’ brands of medical devices from the above categories as the agreement is not for sole supply.
Any changes to the original proposal?
This decision was subject to a consultation letter dated 9 May 2024.
No changes have been made to the proposal since consultation.
Who we think will be most interested
- Health NZ hospital staff
- Clinical engineers and maintenance services
- ICU, emergency, and critical care staff
- Neurologists and Neurosurgeons
- Nurses
- Ophthalmologists
- Perioperative staff
- Procurement and supply chain
- Radiologists
- Sterile services personnel
- Surgeons
- Surgical and general ward staff
- Suppliers and wholesalers
Detail about this decision
In 2021 Pharmac issued an RFP for the supply of surgical implants, medical and surgical instruments and power tools, and associated products.
The RFP was for non-exclusive national agreements for listing on the Pharmaceutical Schedule.
After completing the evaluation processes, and consulting on the provisional agreement with Bio Serve, Pharmac has decided to list Bio Serve’s medical devices in Part III of Section H of the Pharmaceutical Schedule from 1 August 2024.
The list of products will be available on Pharmac’s website from 1 August 2024.
Health NZ hospitals can continue to choose which surgical implants, and medical and surgical instruments and power tools they purchase, including those from other suppliers. Health NZ hospitals that purchase medical devices in these categories must do so under the terms and conditions, including pricing, in the agreement from 1 August 2024.
Our response to what you told us
We are really grateful for the time people took to review this proposal during the consultation period. No feedback was received in relation to this proposal.
If you have any questions about this decision, you can email us at enquiry@pharmac.govt.nz; or call our toll-free number (9 am to 5 pm, Monday to Friday) on 0800 660 050.